Yanan Zhu

Q: What is Yanan Zhu's success rate?

Yanan Zhu currently has a success rate of 91.88494559987535.

Q: What is the average return of Yanan Zhu's calls?

Their stock ratings have generated an average return of 35.704720420548846.

Wells Fargo | Healthcare

Yanan Zhu is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #506 out of 4639 analysts, they have issued 38 stock ratings with a success rate of 91.88% and an average return of 35.70%.

Yanan Zhu has a well-established track record, with 38 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 91.88% and an average return of 35.70%, underscoring their expertise and ability to identify winning opportunities for investors.

#506

Out of 4639

Total Ratings

+91.88%

Success Rate

+35.70%

Average Return

Recent Ratings Analysis

ONC

Buy

May 04, 2026

Target

$400.00

Current

$297.14

Performance

0.00%

Yanan Zhu rated ONC as Overweight on May 04, 2026, setting a price target of 400. Shares have remained stable near 297.14, leaving the 400 target still in play.

SYRE

Buy

Apr 14, 2026

Target

$90.00

Current

$69.13

Performance

8.00%

On Apr 14, 2026, SYRE was given a Overweight rating by Yanan Zhu, with a target price of 90. The stock rallied 8.00% after the rating, narrowing the gap to the target of 90 and validating the bullish stance.

CYTK

Buy

Apr 10, 2026

Target

$95.00

Current

$66.05

Performance

1.60%

CYTK received a Overweight rating from Yanan Zhu on Apr 10, 2026, aiming for 95. Price action was muted, as shares hovered around 66.05 despite the bullish outlook.

RNA

Buy

Mar 11, 2026

Target

$25.00

Current

$12.87

Performance

-13.04%

On Mar 11, 2026, Yanan Zhu published a Overweight outlook on RNA, with a target of 25. Market action contradicted the Buy thesis, as shares slipped to 12.87.

QURE

Buy

Mar 09, 2026

Target

$60.00

Current

$20.68

Performance

14.95%

Yanan Zhu on Mar 09, 2026 assigned QURE a Overweight rating, with a price target of 60. The Buy call aligned well with market performance, producing a gain of 14.95%.

NTLA

Hold

Mar 03, 2026

Target

$15.00

Current

$13.87

Performance

1.91%

On Mar 03, 2026, Yanan Zhu reaffirmed NTLA with a Equal-Weight rating, targeting 15. The neutral call matched muted market action of 1.91%.

SRPT

Buy

Feb 27, 2026

Target

$45.00

Current

$22.04

Performance

31.50%

SRPT was rated Overweight by Yanan Zhu on Feb 27, 2026, with a price objective of 45. A bullish response from the market helped close the gap of 22.96 to the target.

ACLX

Hold

Feb 23, 2026

Target

$115.00

Current

$115.07

Performance

1.16%

On Feb 23, 2026, Yanan Zhu initiated coverage on ACLX with a Equal-Weight rating and target of 115. The stock’s lack of movement around 115.07 aligned with a cautious approach.

RAPT

Hold

Jan 20, 2026

Target

$58.00

Current

$58.01

Performance

0.76%

Yanan Zhu issued a Equal-Weight recommendation for RAPT on Jan 20, 2026, price target set at 58. The rating was appropriate for a consolidating market trading near 58.005.

TSHA

Buy

Jan 05, 2026

Target

$11.00

Current

$6.64

Performance

35.79%

On Jan 05, 2026, TSHA was evaluated by Yanan Zhu, who gave a Overweight rating and target of 11. This case illustrates how a timely bullish rating can translate into tangible gains of 35.79%.

IONS

Buy

Jan 05, 2026

Target

$100.00

Current

$75.45

Performance

-3.92%

Yanan Zhu rated IONS as Overweight on Jan 05, 2026, setting a price target of 100. Shares have remained stable near 75.45, leaving the 100 target still in play.

ARCT

Buy

Oct 23, 2025

Target

$20.00

Current

$8.57

Performance

-28.58%

On Oct 23, 2025, ARCT was given a Overweight rating by Yanan Zhu, with a target price of 20. Despite the Buy call, shares fell from 8.57 to 8.57, challenging the optimistic stance.

EDIT

Hold

Sep 03, 2025

Target

$4.00

Current

$3.00

Performance

20.00%

EDIT received a Equal-Weight rating from Yanan Zhu on Sep 03, 2025, aiming for 4. Investors saw gains of 20.00% that the cautious stance didn’t fully capture.

NAMS

Buy

Aug 25, 2025

Target

$45.00

Current

$29.86

Performance

20.89%

On Aug 25, 2025, Yanan Zhu published a Overweight outlook on NAMS, with a target of 45. Shares gained 20.89%, underscoring the accuracy of the bullish outlook toward 45.

MGX

Buy

Aug 14, 2025

Target

$12.00

Current

$1.41

Performance

-25.79%

Yanan Zhu on Aug 14, 2025 assigned MGX a Overweight rating, with a price target of 12. The call has struggled to gain traction, with shares losing 25.79%.

FATE

Hold

Aug 13, 2025

Target

$2.50

Current

$1.80

Performance

59.29%

On Aug 13, 2025, Yanan Zhu reaffirmed FATE with a Equal-Weight rating, targeting 2.5. Market strength beyond 1.8 went further than the conservative outlook suggested.

AUTL

Buy

Aug 13, 2025

Target

$5.00

Current

$1.57

Performance

-14.67%

AUTL was rated Overweight by Yanan Zhu on Aug 13, 2025, with a price objective of 5. This case shows how bullish projections can fail, with the stock now below 1.57.

IOVA

Buy

Aug 08, 2025

Target

$14.00

Current

$3.85

Performance

82.46%

On Aug 08, 2025, Yanan Zhu initiated coverage on IOVA with a Overweight rating and target of 14. The stock’s climb of 82.46% since the call highlights the foresight in the rating.

AFMD

Hold

May 13, 2025

Target

$0.10

Current

$0.18

Performance

35.45%

Yanan Zhu issued a Equal-Weight recommendation for AFMD on May 13, 2025, price target set at 0.1. A neutral call gave way to stronger-than-expected performance, closing in on 0.1.

RGLS

Buy

Mar 27, 2025

Target

$6.00

Current

$8.16

Performance

444.00%

On Mar 27, 2025, RGLS was evaluated by Yanan Zhu, who gave a Overweight rating and target of 6. This case illustrates how a timely bullish rating can translate into tangible gains of 444.00%.

ADAP

Hold

Mar 21, 2025

Target

$1.50

Current

$0.05

Performance

-83.32%

Yanan Zhu rated ADAP as Equal-Weight on Mar 21, 2025, setting a price target of 1.5. The cautious Hold call aligned with subsequent weakness, as shares slipped 83.32%.

VYGR

Buy

Mar 12, 2025

Target

$10.00

Current

$3.88

Performance

-4.43%

On Mar 12, 2025, VYGR was given a Overweight rating by Yanan Zhu, with a target price of 10. The stock traded sideways with a -4.43% move, keeping the bullish thesis unresolved.

BLUE

Hold

Feb 24, 2025

Target

$5.00

Current

$4.97

Performance

22.72%

BLUE received a Equal-Weight rating from Yanan Zhu on Feb 24, 2025, aiming for 5. Investors saw gains of 22.72% that the cautious stance didn’t fully capture.

CRSP

Hold

May 09, 2024

Target

$65.00

Current

$53.58

Performance

0.06%

On May 09, 2024, Yanan Zhu published a Equal-Weight outlook on CRSP, with a target of 65. Sideways action left the Hold view intact, with no major move since 53.58.

Frequency Asked Questions

Who is Yanan Zhu?

Yanan Zhu is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Yanan Zhu's success rate?

Yanan Zhu currently has a success rate of +91.88%.

How many ratings has Yanan Zhu issued?

Yanan Zhu has issued 38 stock ratings so far.

What is the average return of Yanan Zhu's calls?

Their stock ratings have generated an average return of +35.70%.

What is Yanan Zhu's ranking?

Yanan Zhu is ranked #506 out of 4639 analysts.

What types of ratings does Yanan Zhu give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Yanan Zhu?

You can follow Yanan Zhu by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Yanan Zhu?

Their latest rating was a Buy on ONC issued on 2026-05-04.